Home

atribui Hick contrazice activity markers lupus Revendicare zebră Fişier

Clinical disease activity and flare in SLE: Current concepts and novel  biomarkers - ScienceDirect
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers - ScienceDirect

Urinary biomarkers in lupus nephritis - ScienceDirect
Urinary biomarkers in lupus nephritis - ScienceDirect

Predictive value of autoantibodies for activity of systemic lupus  erythematosus
Predictive value of autoantibodies for activity of systemic lupus erythematosus

New insights into the role of antinuclear antibodies in systemic lupus  erythematosus | Nature Reviews Rheumatology
New insights into the role of antinuclear antibodies in systemic lupus erythematosus | Nature Reviews Rheumatology

IJMS | Free Full-Text | Biomarkers Associated with Organ-Specific  Involvement in Juvenile Systemic Lupus Erythematosus
IJMS | Free Full-Text | Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus

Biomolecules | Free Full-Text | Clinical and Immunological Biomarkers for  Systemic Lupus Erythematosus
Biomolecules | Free Full-Text | Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus

The Study of CD 69 as an Early Marker of SLE Activity in Pediatrics -  SciAlert Responsive Version
The Study of CD 69 as an Early Marker of SLE Activity in Pediatrics - SciAlert Responsive Version

A Review of Complement Activation in SLE | SpringerLink
A Review of Complement Activation in SLE | SpringerLink

Systemic Lupus Erythematosus (SLE) - Cancer Therapy Advisor
Systemic Lupus Erythematosus (SLE) - Cancer Therapy Advisor

Utility of serum ferritin and soluble interleukin-2 receptor as markers of  disease activity in childhood systemic lupus erythematosus. - Abstract -  Europe PMC
Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus. - Abstract - Europe PMC

Cureus | Systemic Lupus Erythematosus and Cardiovascular Disease
Cureus | Systemic Lupus Erythematosus and Cardiovascular Disease

Frontiers | Innate Immune Cells' Contribution to Systemic Lupus  Erythematosus
Frontiers | Innate Immune Cells' Contribution to Systemic Lupus Erythematosus

Cureus | The Shifting Landscape of Lupus Nephritis Management: A Review
Cureus | The Shifting Landscape of Lupus Nephritis Management: A Review

Systemic Lupus Erythematosus | NEJM
Systemic Lupus Erythematosus | NEJM

Frontiers | Emerging Molecular Markers Towards Potential Diagnostic Panels  for Lupus
Frontiers | Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus |  Arthritis Research & Therapy | Full Text
Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus | Arthritis Research & Therapy | Full Text

Longitudinal Variation of Proteomic Biomarkers That Correlate with Efficacy  Endpoints: Results from a Phase 3 Trial of Anifrolumab in Moderate to  Severe Systemic Lupus Erythematosus - ACR Meeting Abstracts
Longitudinal Variation of Proteomic Biomarkers That Correlate with Efficacy Endpoints: Results from a Phase 3 Trial of Anifrolumab in Moderate to Severe Systemic Lupus Erythematosus - ACR Meeting Abstracts

Systemic Lupus Erythematosus | NEJM
Systemic Lupus Erythematosus | NEJM

Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Systemic Lupus  Erythematosus: Relation With Disease Activity and L
Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Systemic Lupus Erythematosus: Relation With Disease Activity and L

Systemic Lupus Erythematosus - Rheumatology Advisor
Systemic Lupus Erythematosus - Rheumatology Advisor

Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies:  Trends in Molecular Medicine
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies: Trends in Molecular Medicine